Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Investment Surge in Crypto Products Rises for the 11th Straight Week

Investment Surge in Crypto Products Rises for the 11th Straight Week

CointurkCointurk2025/07/01 16:48
By:İlayda Peker

In Brief Cryptocurrency investment products saw an $2.7 billion influx last week. The US led by contributing $2.65 billion to the weekly inflow. Bitcoin and Ethereum dominate, with other altcoins seeing smaller inflows.

Recent findings from CoinShares highlight significant growth in cryptocurrency-based investment products, with a remarkable $2.7 billion inflow last week. This marks the 11th consecutive week of net inflows. The total inflow in the first half of the year has reached $16.9 billion, closely approaching the $18.3 billion total for June 2024. The United States contributed nearly all of this week’s inflow, amounting to $2.65 billion.

Investor Preferences in Bitcoin and Altcoins

Bitcoin (BTC) $106,163 remains a dominant choice, comprising 83% of the weekly total inflow, equal to $2.2 billion. Reflecting this bullish sentiment, there was a $2.9 million outflow from short Bitcoin products, accumulating a $12 million total outflow since the beginning of the year.

Investment Surge in Crypto Products Rises for the 11th Straight Week image 0

Ethereum (ETH) $2,428 investment products also saw substantial activity, with a notable $429 million inflow. Since the start of the year, Ethereum has attracted over $2.9 billion in net investments, indicating persistent confidence from investors.

Meanwhile, major altcoins like Solana $148 ( SOL ) observed more modest inflows, with only $91 million total inflow since the start of the year. Other altcoins such as XRP received $10.6 million last week, Sui $1.4 million, Cardano $0.547337 ( ADA ) $700,000, and Chainlink $13 ( LINK ) $800,000. Litecoin (LTC) products saw no net movement.

This scenario shows that a substantial portion of investor capital is concentrated on Bitcoin and Ethereum-based products.

US Dominates Regional Fund Flow

The United States led the regional inflows dominantly with a net of $2.65 billion. In contrast, Switzerland saw $23 million, and Germany $19.8 million, reflecting much smaller-scale inflows.

On the other hand, Canada reported a $13.6 million outflow, Brazil $2.4 million, and notably, Hong Kong experienced a $2.3 million outflow. Hong Kong is witnessing a consistent outflow trend, with a net outflow of $132 million in June alone following recent price increases.

These regional differences point to varying risk perceptions and regulatory environments across the global investment landscape, with the US maintaining a significant leadership position.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stock IPO Preview | From Losses to Net Profit of 5.46 Million: The "Three-Dimensional" Platform Business Strategy with a Taste for Golf

Crossing the break-even line, the growth inflection point has arrived.

智通财经•2026/11/11 03:22

Core CPI Exceeds Expectations Again, Fed Hawks Loud! 2027 FOMC Voting Member Directly Calls Inflation Hot

Austan Goolsbee, President of the Chicago Federal Reserve, stated that officials must address the issue of high inflation, and described the October consumer price report as worrisome.

智通财经•2026/11/11 03:06

Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality

The FDA requires all GLP-1 drugs to include a warning about the rare eye disease NAION. Novo Nordisk and Eli Lilly deny any causality, while Citi states that the impact on adoption is limited.

智通财经•2026/11/11 02:56
Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality